Temozolomide-Associated Liver Fibrosis

J Clin Pharmacol. 2016 Nov;56(11):1448-1449. doi: 10.1002/jcph.753.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / adverse effects
  • Dacarbazine / adverse effects
  • Dacarbazine / analogs & derivatives*
  • Humans
  • Liver Cirrhosis / chemically induced*
  • Male
  • Middle Aged
  • Temozolomide

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide